Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-12
2011-07-12
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S230200
Reexamination Certificate
active
07977327
ABSTRACT:
A quinolone antibacterial compound, or a salt or hydrate of the compound, for the treatment of infectious diseases, which exhibit potent antibacterial activity and higher selective toxicity against Gram-positive and Gram-negative bacteria, which do not cause side effects (e.g., convulsion), which exhibit higher safety, and which has a structure of formula (I):
REFERENCES:
patent: 4782180 (1988-11-01), Wemple et al.
patent: 4801584 (1989-01-01), Yokose et al.
patent: 4864023 (1989-09-01), Yokose et al.
patent: 6656952 (2003-12-01), Takemura et al.
patent: 2006/0264428 (2006-11-01), Takahashi et al.
patent: 0 208 210 (1987-01-01), None
patent: 1 712 554 (2006-10-01), None
patent: 62 215572 (1987-09-01), None
patent: 63-132891 (1988-06-01), None
patent: 5 59052 (1993-03-01), None
patent: 5 163244 (1993-06-01), None
patent: 7 300416 (1995-11-01), None
patent: 8 259561 (1996-10-01), None
patent: 98 58923 (1998-12-01), None
patent: WO 03/076428 (2003-09-01), None
patent: WO 03/097634 (2003-11-01), None
patent: WO 2004/058261 (2004-07-01), None
Kawakami K, Takahashi H, Ohki H, Kimura K, Miyauchi S, Miyauchi R, Takemura M. Studies on 8-methoxyquinolones: synthesis and antibacterial activity of 7-(3-amino-4-substituted)pyrrolidinyl derivatives. Chem Pharm Bull (Tokyo). 48(11):1667-72, 2000.
Williams et al (Foye's Principles of Medicinal Chemistry, 5th Ed., pp. 59-61, 2002).
Penning et al (J Med Chem 40:1347-1365, 1997).
U.S. Appl. No. 12/422,726, filed Apr. 13, 2009, Takahashi, et al.
Katsuhiro Kawakami, et al., “Synthesis and Antibacterial Activity of Novel Pyridobenzoxazine Analogues”, Chemical and Pharmaceutical Bulletin, vol. 46, No. 11, 1998, pp. 1710-1715.
Japanese Office Action issued Jan. 5, 2011 in Japanese Patent Application No. 2006-513359 published Apr. 20, 2006.
D. Bouzard, et al., “Fluoronaphthyridines and Quinolones as Antibacterial Agents. 2. Synthesis and Structure-Activity Relationship of New 1-tert-Butyl 7-Substituted Derivatives”, Journal of Medicinal Chemistry, 1990, vol. 33, No. 5, pp. 1344-1352.
K. W. Lee. et al., “Quantitative structure-activity relationship (QSAR) study by use of theoretical descriptors: quinolone and naphthyridine”, Bulletin of the Korean Chemical Society, 1994, vol. 15, No. 12, pp. 1070-7079.
Hayakawa Isao
Kuroyanagi Junichi
Miyauchi Rie
Nagamochi Masatoshi
Takahashi Hisashi
Daiichi Sankyo Company, Limited
Fetterolf Brandon J
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Ricci Craig
LandOfFree
Substituted pyrrolidine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolidine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolidine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695851